Roberta B.
- Country
- Italy
- Department
- Ematologia
Research Overview
- Phase 3 Study of Acalabrutinib with R-CHOP in Patients Aged ≤75 with Untreated Non-Germinal Center Diffuse Large B-Cell Lymphoma
- Randomized Phase III Study of Prednisolone and Vitamin D Supplementation in Elderly Patients with Diffuse Large B-Cell Lymphoma (DLBCL)
- Phase I/IIb Study of Atezolizumab with BEGEV Regimen in Relapsed/Refractory Hodgkin's Lymphoma for Autologous Stem-Cell Transplantation Candidates
Data & Insights
Has run more than one trial at 35 of 162 partner sites.
Specializations
Lymphoma Research Focus
This investigator specializes in treating various forms of lymphoid malignancies, with particular emphasis on Diffuse Large B-Cell Lymphoma (DLBCL) and its variants. Their research encompasses both elderly patient populations and aggressive lymphoma subtypes.
- B-Cell Lymphoma Management
- Elderly Patient Care
- Novel Treatment Combinations
Advanced Therapeutic Approaches
The investigator explores innovative therapeutic strategies including immunochemotherapy and targeted treatments. Their work includes research on Hodgkin's lymphoma and Plasmablastic lymphoma, investigating novel drug combinations and treatment protocols.
- Immunotherapy Applications
- Salvage Treatment Strategies
- Combination Therapy Protocols
Treatment Innovation
The investigator focuses on developing therapeutic combinations for various lymphoma subtypes, including research into prephase treatments and novel drug combinations. Their work extends to relapsed and refractory disease management.
- Clinical Trial Development
- Treatment Optimization
- Drug Resistance Management
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.